DEC 23, 2016 02:16 PM PST

Protein That Removes RNA Modification Linked to Leukemia

WRITTEN BY: Carmen Leitch

New evidence from researchers at the University of Cincinnati (UC) College of Medicine has indicated that a protein called FTO, which has been associated with obesity, has a role in the development of leukemia, as well as how drugs respond to it. The work could aid in the development of more effective therapies for the disease. The study, led by Jianjun Chen, an Associate Professor in the Department of Cancer Biology at UIC, has been published in Cancer Cell.

 Jianjun Chen, Ph.D., Associate Professor in the Department of Cancer Biology at the UC College of Medicine. / Credit: University of Cincinnati

In 2011, a co-senior author of this paper, Dr. Chuan He, demonstrated that FTO can remove a type of RNA modification, N6-methyladenosine or m6A RNA methylation. The m6A modification has been shown to be the most common type of alteration to messenger RNAs (mRNAs), which act as an intermediary between genes and the proteins they code for. Cells use RNA modifications to control gene expression. This work has shown that the m6A modification is reversible, and reinforced the likelihood that it has significant biological importance.

 

"Recent studies have shown that m6A modification in mRNAs or non-coding RNAs plays critical roles in virtually all major normal biological processes such as tissue development and stem cell self-renewal and differentiation,” said Chen. However, little is known about the biological importance of m6A modification in the regulation of cancer-causing genes and/or tumor-suppressing genes in the development of tumors."

 

 In this report, the investigators utilized a microarray of acute myeloid leukemia (AML) and control samples. They discovered that FTO was expressed at high levels in subtypes of leukemias that carried mutations in certain genes as well as those that had genetic exchange between chromosomes – chromosome crossover. Increased expression of FTO contributed to the proliferation of cancer cells, supported the growth of leukemia in animal models, and was seen in cases that were not responsive to therapeutics.

 

The investigators also found that genes that have been reported to inhibit the growth of leukemia, ASB2 and RARA, are suppressed in the AML samples that had a high level of FTO expression. It is thought that the m6A demthylase action of FTO reduces the stability of the mRNAs of those genes.

 

"Our study shows, for the first time, the functional importance of the m6A modification machinery in leukemia," said Chen. "In addition, given the functional importance of FTO in the formation of leukemia and drug response, targeting FTO signaling may present a new therapeutic strategy to treat leukemia. As FTO may also play a cancer-promoting role in various types of solid tumors, besides leukemia, our discoveries may have a broad impact in cancer biology and cancer therapy. Further studies are needed to advance our understanding of the critical role of FTO in various types of cancers and to develop more effective novel therapeutic strategies based on such understanding to treat cancers."

 

If you would like to know more about the m6A modification and how it relates to diabetes and cancer, check out the following talk from Professor Tsvee Lapidot, Incumbent of the Edith Arnoff Stein Professorial Chair in Stem Cell Research in the Immunology Department of the Weizmann Institute of Science. Around the fifth minute the talk gets going, when RNA modifications are introduced, and around minute ten, FTO is mentioned and the relationship between the m6A modifications and disease is discussed later in the talk.

 

Sources: AAAS/Eurekalert! via UIC, Cancer Cell

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 07, 2018
Genetics & Genomics
NOV 07, 2018
Hunting Down the microRNAs That Influence Disease
Researchers want to identify the tiny, non-coding RNAs that control gene expression - and contribute to disease....
NOV 13, 2018
Cell & Molecular Biology
NOV 13, 2018
The Mechanism of a Cell-penetrating Peptide is Revealed
Cells have a barrier around them, which carefully controls what can move across it. That presents a challenge in pharmaceutical design....
NOV 26, 2018
Neuroscience
NOV 26, 2018
Conditioned Taste Aversion (CTA)
The negative reaction to certain foods when encountering a food due to adverse post ingestion consequences is called Conditioned Taste Aversion (CTA)....
DEC 01, 2018
Videos
DEC 01, 2018
Identifying Disease-causing Gene Mutations
Genetic diseases can be traced back to an error in a gene. This video explores how the process works....
DEC 15, 2018
Genetics & Genomics
DEC 15, 2018
Neanderthal Genes Provide Insight Into Human Brain Evolution
Neanderthal heads are almost football-shaped, while modern humans have much rounder brains and skulls....
DEC 17, 2018
Drug Discovery
DEC 17, 2018
Alzheimer Preventing Drug Could Work Like A Vaccine
Researchers at UT Southwestern believe that a protein called ApoE is the primary factor in late-onset Alzheimer's disease. Such conclusion has to inspi...
Loading Comments...